Andrea C Aguilera1, Isabelle A Dagher2, Kirsten M Kloepfer3,4,5. 1. Department of Pediatrics, Indiana School of Medicine, 705 Riley Hospital Drive, RI 2606, Indianapolis, IN, 46202, USA. 2. Indiana University School of Medicine, 705 Riley Hospital Drive, RI 2606, Indianapolis, IN, 46202, USA. 3. Department of Pediatrics, Indiana School of Medicine, 705 Riley Hospital Drive, RI 2606, Indianapolis, IN, 46202, USA. kloepfer@iu.edu. 4. Indiana University School of Medicine, 705 Riley Hospital Drive, RI 2606, Indianapolis, IN, 46202, USA. kloepfer@iu.edu. 5. Division of Pulmonary, Allergy and Sleep Medicine, Department of Pediatrics, Indiana University School of Medicine, 705 Riley Hospital Drive, RI 2606, Indianapolis, IN, 46202, USA. kloepfer@iu.edu.
Abstract
PURPOSE OF REVIEW: Evidence suggests that the microbiome of the skin, gastrointestinal tract, and airway contribute to health and disease. As we learn more about the role that the microbiota plays in allergic disease development, we can develop therapeutics to alter this pathway. RECENT FINDINGS: Epidemiologic studies reveal that an association exists between environmental exposures, which alter the microbiota, and developing atopic dermatitis, food allergy, and/or asthma. In fact, samples from the skin, gastrointestinal tract, and respiratory tract reveal distinct microbiotas compared with healthy controls, with microbial changes (dysbiosis) often preceding the development of allergic disease. Mechanistic studies have confirmed that microbes can either promote skin, gut, and airway health by strengthening barrier integrity, or they can alter skin integrity and damage gut and airway epithelium. In this review, we will discuss recent studies that reveal the link between the microbiota and immune development, and we will discuss ways to influence these changes.
PURPOSE OF REVIEW: Evidence suggests that the microbiome of the skin, gastrointestinal tract, and airway contribute to health and disease. As we learn more about the role that the microbiota plays in allergic disease development, we can develop therapeutics to alter this pathway. RECENT FINDINGS: Epidemiologic studies reveal that an association exists between environmental exposures, which alter the microbiota, and developing atopic dermatitis, food allergy, and/or asthma. In fact, samples from the skin, gastrointestinal tract, and respiratory tract reveal distinct microbiotas compared with healthy controls, with microbial changes (dysbiosis) often preceding the development of allergic disease. Mechanistic studies have confirmed that microbes can either promote skin, gut, and airway health by strengthening barrier integrity, or they can alter skin integrity and damage gut and airway epithelium. In this review, we will discuss recent studies that reveal the link between the microbiota and immune development, and we will discuss ways to influence these changes.
Authors: Carina Venter; Kate Maslin; John W Holloway; Lori J Silveira; David M Fleischer; Taraneh Dean; S Hasan Arshad Journal: J Allergy Clin Immunol Pract Date: 2020-01-28
Authors: Giske Biesbroek; Astrid A T M Bosch; Xinhui Wang; Bart J F Keijser; Reinier H Veenhoven; Elisabeth A M Sanders; Debby Bogaert Journal: Am J Respir Crit Care Med Date: 2014-08-01 Impact factor: 21.405
Authors: Ilan Youngster; George H Russell; Christina Pindar; Tomer Ziv-Baran; Jenny Sauk; Elizabeth L Hohmann Journal: JAMA Date: 2014-11-05 Impact factor: 56.272
Authors: Markus Johannes Ege; Remo Frei; Christian Bieli; Dieneke Schram-Bijkerk; Marco Waser; Marcus R Benz; Gertraud Weiss; Fredrik Nyberg; Marianne van Hage; Göran Pershagen; Bert Brunekreef; Josef Riedler; Roger Lauener; Charlotte Braun-Fahrländer; Erika von Mutius Journal: J Allergy Clin Immunol Date: 2007-03-08 Impact factor: 10.793